ey0017.9-5 | Fertility-Related Issues | ESPEYB17
W Chemaitilly , Q Liu , L van Iersel
ey0018.9-11 | Cancer treatment, growth and growth hormone therapy | ESPEYB18
M Mizumoto , Y Oshiro , H Pan , F Wang , SC Kaste , A Gajjar , W Chemaitilly , TE. thomas.merchant@stjude.org Merchant
ey0016.9-12 | Cancer Treatment and Growth Disorders | ESPEYB16
JG Sfeir , NEN Kittah , SU Tamhane , S Jasim , W Chemaitilly , LE Cohen , MH Murad
ey0016.9-14 | Cancer Treatment and Growth Disorders | ESPEYB16
S Tamhane , JG Sfeir , NEN Kittah , S Jasim , W Chemaitilly , LE Cohen , MH Murad
ey0020.7-13 | Long-Term Surveillance for Endocrine Complications in Childhood Cancer Survivors | ESPEYB20
JJG Welch , B Ames , LE Cohen , E Gaufberg , MM Hudson , PC Nathan , L Nekhlyudov , TI Yock , W Chemaitilly , LB Kenney
ey0016.9-1 | Long Term Outcomes of Childhood Cancer: A Changing Burden | ESPEYB16
DA Mulrooney , G Hyun , KK Ness , N Bhakta , CH Pui , MJ Ehrhardt , KR Krull , DB Crom , W Chemaitilly , DK Srivastava , MV Relling , S Jeha , DM Green , Y Yasui , LL Robison , MM Hudson
ey0015.9-1 | Late consequences of tumour therapy: prevention and monitoring | ESPEYB15
MJ Ehrhardt , JT Sandlund , N Zhang , W Liu , KK Ness , N Bhakta , W Chemaitilly , KR Krull , TM Brinkman , DB Crom , L Kun , SC Kaste , GT Armstrong , DM Green , K Srivastava , LL Robison , MM Hudson , DA Mulrooney
ey0018.9-8 | Genetic susceptibility to treatment-related gonadotoxicity | ESPEYB18
ALF van der Kooi , M van Dijk , L Broer , MH van den Berg , JSE Laven , FE van Leeuwen , CB Lambalk , A Overbeek , JJ Loonen , HJ van der Pal , WJ Tissing , B Versluys , D Bresters , CCM Beerendonk , CR Ronckers , M van der Heiden-van der Loo , GL Kaspers , ACH de Vries , LL Robison , MM Hudson , W Chemaitilly , J Byrne , C Berger , E Clemens , U Dirksen , J Falck Winther , SD Fossa , D Grabow , R Haupt , M Kaiser , T Kepak , J Kruseova , D Modan-Moses , SMF Pluijm , C Spix , O Zolk , P Kaatsch , JH Krijthe , LC Kremer , Y Yasui , RJ Brooke , AG Uitterlinden , M van den Heuvel-Eibrink , E Mvan Dulmen-den Broeder
ey0019.9-1 | Cancer treatment and growth hormone therapy: a consensus | ESPEYB19
MCS Boguszewski , CL Boguszewski , W Chemaitilly , LE Cohen , J Gebauer , C Higham , AR Hoffman , M Polak , KCJ Yuen , N Alos , Z Antal , M Bidlingmaier , BMK Biller , G Brabant , CSY Choong , S Cianfarani , PE Clayton , R Coutant , AA Cardoso-Demartini , A Fernandez , A Grimberg , K Guðmundsson , J Guevara-Aguirre , KKY Ho , R Horikawa , AM Isidori , JOL Jorgensen , P Kamenicky , N Karavitaki , JJ Kopchick , M Lodish , X Luo , AI McCormack , L Meacham , S Melmed , Moab S Mostoufi , HL Muller , SJCMM Neggers , Oliveira MH Aguiar , K Ozono , PA Pennisi , V Popovic , S Radovick , L Savendahl , P Touraine , HM van Santen , G Johannsson
ey0020.7-14 | Long-Term Surveillance for Endocrine Complications in Childhood Cancer Survivors | ESPEYB20
L van Iersel , RL Mulder , C Denzer , LE Cohen , HA Spoudeas , LR Meacham , E Sugden , AYN Schouten-van Meeteren , EW Hoving , RJ Packer , GT Armstrong , S Mostoufi-Moab , AM Stades , D van Vuurden , GO Janssens , C Thomas-Teinturier , RD Murray , N Di Iorgi , SJCMM Neggers , J Thompson , AA Toogood , H Gleeson , C Follin , E Bardi , L Torno , B Patterson , V Morsellino , G Sommer , SC Clement , D Srivastava , CE Kiserud , A Fernandez , K Scheinemann , S Raman , KCJ Yuen , WH Wallace , LS Constine , R Skinner , MM Hudson , LCM Kremer , W Chemaitilly , HM van Santen